跳至主要内容
临床试验/CTRI/2026/01/100590
CTRI/2026/01/100590尚未招募不适用

AN INTEGRATED PHYSIOTHERAPEUTIC APPROACH IN MANAGING POST LUMPECTOMY LYMPHEDEMA:A RANDOMIZED CONTROLLED TRIAL

SHIKHA GUPTA1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2026年1月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
400
试验地点
1

研究概览

简要总结

BREAST CANCER RELATED LYMPHEDEMA IS A COMMON CHRONIC COMPLICATION AMONG BREAST CANCER SURVIVORS OFTEN RESULTING IN PERSISTENT SWELLING TISSUE FIBROSIS PAIN REDUCED MOBILITY AND POOR QUALITY OF LIFE  WHILE STANDARD COMPLETE DECONGESTIVE THERAPY COMPRISING MANUAL LYMPHATIC DRAINAGE COMPRESSION BANDAGING EXERCISES AND SKIN CARE REMAINS THE MAINSTAY OF TREATMENT MANY SURVIVORS CONTINUE TO SUFFER FUNCTIONAL TISSUE AND PSYCHOLOGICAL SEQUELE

THIS RANDOMIZED CONTEOLLED TRIAL AIMS TO EVALUATE WHETHER AN INTEGRATED PHYSIOTHERAPEUTIC APPROACH COMBINING CDT WITH INTERMITTENT PNEUMATIC COMPRESSION SOFT TISSUE MOBILIZATION THERAPEUTIC EXERCISES PLUS PROGRESSIVE MUSCLE RELAXATION PRODUCES SUPERIOR OUTCOMES COMPARED WITH STANDARD CDT ALONE OVER SIX WEEKS IN POST LUMPECTOMY WOMEN WITH STAGE 2 AND 3 BCRL

OUTCOMES INCLUDE LIMB VOLUME REDUCTION RANGE OF MOTION PAIN STRENGTH FATIQUE ARTERIAL CIRCULATION AND PSYCHOLOGICAL MEASURES LIKE ANXIETY BODY IMAGE QUALITY OF LIFE ASSESSED AT BASELINE AND AT WEEK 6

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • BREAST CANCER FEMALE AGED ABOVE 18 YEARS WHO UNDERGONE BREAST CANCER SUREGERY AND HAD LYMPHEDEMA STAGE 2 AND 3, HAVING SYMPTOM OF PAIN, HRAVINESS AND FIBROSIS, ABLE TO FOLLOW THE COMMANDS AND AGREE TO WEAR COMPRESSION GARMENT OR BANDAGING FOR 12 HOURS PER DAY.

排除标准

  • PATIENTS WHO UNDERGOING OR SCHEDULED A CHEMOTHERAPY OR RADIATION THERAPY, PRESENT WITH LIMB INFECTION,DVT, OR HAS ACTIVE METASTATIC DISEASE, HAS NEUROLOGICAL OR COGNITIVE DEFICITS, HAS ANY CONTRADICTIONS TO USE COMPRESSION ON LIMB.

研究者

发起方
SHIKHA GUPTA
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

SHIKHA GUPTA

SGT UNIVERSITY

研究点 (1)

Loading locations...

相似试验